New Hampshire Trust Has $626,000 Stock Holdings in The Allstate Corporation $ALL

New Hampshire Trust raised its stake in shares of The Allstate Corporation (NYSE:ALL) by 4.7% during the second quarter, Holdings Channel reports. The firm owned 3,112 shares of the insurance provider’s stock after buying an additional 140 shares during the period. New Hampshire Trust’s holdings in Allstate were worth $626,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD raised its stake in shares of Allstate by 25.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 11,709,610 shares of the insurance provider’s stock valued at $2,424,710,000 after acquiring an additional 2,374,684 shares during the last quarter. Boston Partners raised its stake in shares of Allstate by 613.9% in the first quarter. Boston Partners now owns 2,482,654 shares of the insurance provider’s stock valued at $512,627,000 after acquiring an additional 2,134,893 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in shares of Allstate by 27.2% in the first quarter. Goldman Sachs Group Inc. now owns 2,328,070 shares of the insurance provider’s stock valued at $482,073,000 after acquiring an additional 497,982 shares during the last quarter. Strs Ohio bought a new position in shares of Allstate in the first quarter valued at approximately $84,408,000. Finally, AQR Capital Management LLC raised its stake in shares of Allstate by 20.3% in the first quarter. AQR Capital Management LLC now owns 2,018,403 shares of the insurance provider’s stock valued at $417,244,000 after acquiring an additional 340,150 shares during the last quarter. 76.47% of the stock is owned by institutional investors and hedge funds.

Allstate Price Performance

Shares of ALL stock opened at $193.37 on Friday. The Allstate Corporation has a 12-month low of $176.00 and a 12-month high of $215.70. The firm has a market capitalization of $50.95 billion, a price-to-earnings ratio of 9.09, a price-to-earnings-growth ratio of 0.70 and a beta of 0.38. The company has a quick ratio of 0.43, a current ratio of 0.43 and a debt-to-equity ratio of 0.37. The firm has a fifty day moving average of $204.27 and a 200-day moving average of $201.08.

Allstate (NYSE:ALL) last announced its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $5.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.20 by $2.74. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The company had revenue of $15.05 billion during the quarter, compared to analyst estimates of $16.59 billion. During the same quarter in the previous year, the business earned $1.61 EPS. The firm’s revenue was up 5.8% on a year-over-year basis. On average, equities research analysts forecast that The Allstate Corporation will post 18.74 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Citigroup upgraded shares of Allstate to a “hold” rating in a research report on Wednesday, August 13th. Morgan Stanley boosted their price objective on shares of Allstate from $235.00 to $245.00 and gave the stock an “overweight” rating in a research report on Friday, August 1st. Evercore ISI set a $233.00 price objective on shares of Allstate and gave the stock an “in-line” rating in a research report on Wednesday, October 1st. UBS Group boosted their price objective on shares of Allstate from $235.00 to $250.00 and gave the stock a “buy” rating in a research report on Wednesday, October 8th. Finally, Wells Fargo & Company dropped their price objective on shares of Allstate from $200.00 to $197.00 and set an “equal weight” rating for the company in a research report on Friday. Two research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $234.27.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.